Navigation Links
Aimago Strengthens and Expands IP Portfolio
Date:8/26/2013

LAUSANNE, Switzerland, Aug. 26, 2013 /PRNewswire-iReach/ -- Aïmago SA, a Swiss medical device company and developer of the Aïmago EasyLDI Perfusion Camera, announces that a core patent for the real-time and non-invasive skin perfusion visualization has been granted in the US. As a result, Aïmago has completed a technology transfer process with the Swiss Federal Institute of Technology in Lausanne (EPFL), including the license of patent applications on the integration of Laser Doppler Imaging (LDI) with ICG / fluorescence imaging.

This further strengthens Aïmago's position as technology leader in clinically relevant perfusion imaging to assess both skin perfusion and deep tissue / organ perfusion within one device.

Granted Patent Protects LDI Ready for Effortless Clinical Use

The recently granted patent (US 8,480,579 B2) protects Aïmago's EasyLDI Perfusion Camera's ability to make LDI real-time by replacing the traditionally used and slow scanning systems with Aïmago's innovative, fast and full-field imaging approach.  Aïmago's patented technology enables EasyLDI to be compact and provide highly intuitive and real-time images for use by surgeons, physicians and nurses.

Combining the Best of Both Worlds

EasyLDI is based on LDI and the most advanced solution for skin perfusion assessment across plastic and reconstructive surgery, burns and advanced wound care, as well as peripheral vascular and extremity applications. It is non-invasive and allows for immediate and continuous imaging much like using a digital camera – both inside and outside the operating room.

In parallel, ICG / fluorescence based perfusion imaging is widely available and an established standard in ophthalmology and neurosurgery. Contrary to LDI, ICG requires the injection of a dye and thus cannot be used continuously, but it has the ability to visualize blood flow in large vessels and inner organs.

While the principle of ICG / fluorescent based perfusion imaging is in public domain, the now licensed patent applications seek to protect the combination of LDI with ICG / fluorescence imaging into one single imaging device. These patent applications, filed in 2007, are currently in review phases in both the United States and Germany.

Prof. Theo Lasser, head of the EPFL Biomedical Optics Lab and co-founder of Aïmago, has experience with ICG and comments: "We are satisfied to see that Aïmago now has access to the entire IP package. From a clinical perspective, the implemented LDI modality covers the majority of applications related to skin perfusion imaging, while ICG / fluorescence imaging opens the door to deeper tissues and organs – all through one single, highly intuitive instrument."

About Aïmago

Aïmago is a privately held, medical device company founded as a spin-off from EPFL in 2008. The tablet-inspired and FDA cleared Aïmago EasyLDI Perfusion Camera empowers clinicians and nurses to obtain clinically relevant, objective and repeatable insights into the perfusion reality. Emphasizing on usability, EasyLDI essentially works like a point-and-shoot camera: No injections, no turning-off the ambient light, no extra personnel, no waiting, and no limitations to use. The company has won several awards, including the CTI MedTech Award 2011 from the Swiss government and the W.A. de Vigier Award for best Swiss start-up. More information is available at www.aimago.com.

Media Contact: Michael Friedrich, Aïmago SA, +41215105560, michael.friedrich@aimago.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Aïmago SA
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Commercial Release of 3D (Breast Tomosynthesis) Biopsy Option Strengthens Hologics Position as Provider of the Nations Most Comprehensive Portfolio of Interventional Breast Health Solutions
2. OxThera Strengthens Patent Portfolio for Orphan Disease - Primary Hyperoxaluria
3. Global Pharmaceutical Company Strengthens Compliance Using Vault PromoMats and Veeva CRM
4. TransCelerate BioPharma Inc. Grows, Strengthens Novel Effort to Accelerate Drug Development
5. Neuland Labs Strengthens Commitment to Japanese Market With New Manufacturing Collaboration With Mitsubishi Healthcare Unit API Corporation
6. Alliqua Strengthens and Realigns Executive Team
7. inVentiv Health Strengthens Clinical Leadership Team
8. Jardogs Strengthens Leadership Team with the Addition of Two Seasoned Healthcare Executives
9. Pharmalink AB Strengthens Senior Management Team
10. Actinium Pharmaceuticals Strengthens Management Team
11. PAREXEL Strengthens Outcomes Research Capabilities To Help Biopharma Meet Commercialization Goals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Medical Market Analysis 2016 - Forecast to 2022" report ... The report contains up to date financial data derived from ... of major trends with potential impact on the market during ... market segmentation which comprises of sub markets, regional and country ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at www.diabetesscholars.org by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
(Date:6/24/2016)... ... , ... National recruitment firm Slone Partners is pleased to announce ... experience, as Vice President of North American Capital Sales at HTG Molecular . ... sales team in the commercialization of the HTG EdgeSeq system and associated reagents in ...
Breaking Medicine News(10 mins):